Background information on HIV, hepatitis C and STIs in Canada, including basic information, statistics (epidemiology), provincial and national strategies to address HIV, hepatitis C and STIs, and social determinants of health.
Information on HIV and hepatitis C transmission and prevention, including STIs and safer sex, harm reduction, pregnancy and infant feeding, and microbicides and vaccines.
Information on diagnostic tests for HIV, hepatitis C and STIs; the delivery of testing and counselling; and resources for people who are newly diagnosed.
Information on treatment, care and support for HIV, hepatitis C and STIs, including medications, healthy living, pregnancy and infant feeding, hepatitis C re-infection, and long-term health issues.
CATIE’s online educational courses, webinars, online and print publications, and other websites.
CATIE is Canada’s source for HIV and hepatitis C information, and so much more. We increase knowledge about sexual health and substance use, we build the capacity of service providers to deliver prevention, testing and treatment services, and we promote policies and programs proven to work based on research, practice and lived experience.
Data from the Canadian Coroner and Medical Examiner Database (CCMED) on apparent toxicity deaths caused by xylazine in Canada, 2019 to 2024.
